Azzad Asset Management’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-21,858
Closed -$1.37M 356
2026
Q1
$1.37M Sell
21,858
-228
-1% -$18.2K 0.14% 193
2025
Q4
$2.11M Sell
22,086
-55
-0.2% -$5.39K 0.21% 158
2025
Q3
$2.16M Sell
22,141
-418
-2% -$43.3K 0.21% 161
2025
Q2
$2.42M Buy
22,559
+86
+0.4% +$8.7K 0.26% 151
2025
Q1
$2.27M Buy
+22,473
New +$2.26M 0.27% 148
2017
Q2
Sell
-30,087
Closed -$748K 295
2017
Q1
$748K Buy
30,087
+2,241
+8% +$54.5K 0.28% 144
2016
Q4
$602K Buy
27,846
+616
+2% +$13.4K 0.25% 152
2016
Q3
$648K Sell
27,230
-559
-2% -$13.3K 0.27% 139
2016
Q2
$649K Sell
27,789
-3,480
-11% -$75.3K 0.28% 138
2016
Q1
$588K Buy
31,269
+4,875
+18% +$85.6K 0.26% 151
2015
Q4
$487K Buy
26,394
+5,638
+27% +$101K 0.23% 159
2015
Q3
$341K Buy
+20,756
New +$355K 0.18% 194

Other funds holding BSX

Azzad Asset Management's BSX Position: Q2 2026 in Review

Azzad Asset Management sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 21,858 shares — an estimated $1.37M sold.

Azzad Asset Management first reported a position in BSX in Q3 2015 and held it in 12 quarters. The position peaked at $2.42M in Q2 2025. 534 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Azzad Asset Management reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
  • Azzad Asset Management sold 21,858 Boston Scientific shares in Q2 2026, an estimated $1.37M.
  • Azzad Asset Management first reported a position in Boston Scientific in Q3 2015 and held it in 12 quarters.
  • Azzad Asset Management's Boston Scientific position peaked at $2.42M in Q2 2025.
  • 534 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Azzad Asset Management's 13F filing for Q2 2026, filed 29 Jul 2026.